Related Experiment Video
Updated: Jan 11, 2026
01:27
Disorders of Erythrocytes
2.0K
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
Patrick P J Phillips1, Carole D Mitnick2, James D Neaton3
1School of Medicine, UCSF Center for TB, University of California San Francisco, San Francisco, California, United States of America.
Plos Medicine
|March 23, 2019
Summary
Patrick Phillips and colleagues review advancements in clinical trial design for tuberculosis (TB) therapeutics. This collection highlights key developments in evaluating new TB treatments.
Area of Science:
- Medicine
- Clinical Research
- Pharmacology
Background:
- Tuberculosis (TB) remains a significant global health challenge, necessitating novel therapeutic strategies.
- Traditional clinical trial designs may not be optimal for rapidly evaluating new TB drugs.
- Advancements in clinical trial methodologies are crucial for accelerating the development of effective TB treatments.
Purpose of the Study:
- To review and discuss recent developments in clinical trial design for tuberculosis therapeutics.
- To highlight innovative approaches for evaluating the efficacy and safety of new TB drugs.
- To provide insights into optimizing the clinical evaluation process for TB therapeutics.
Main Methods:
- The authors conducted a comprehensive review of existing literature and recent publications.
- Key developments in clinical trial design were identified and analyzed.
- The review focused on innovative methodologies applicable to TB therapeutic evaluation.
Main Results:
- Several novel clinical trial designs are emerging for TB therapeutics.
- These developments aim to improve efficiency, reduce timelines, and enhance the evaluation of drug efficacy.
- The review synthesizes current trends and future directions in TB clinical trial design.
Conclusions:
- Innovations in clinical trial design are vital for the accelerated development of new tuberculosis drugs.
- Adoption of advanced methodologies can improve the evaluation of TB therapeutics.
- Continued research and implementation of novel trial designs are essential to combat TB globally.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
01:27Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
02:45Blood Transfusion and Agglutination
14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
01:19Rh Blood Group
2.7K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.7K
01:15Blood Transfusion
2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
01:10Blood Typing
2.3K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
2.3K